Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 994-999

  Kaufmann, R ^a   Spelman, L ^b   Weightman, W ^c   Reifenberger, J ^d   Szeimies, R M ^e   Verhaeghe, E ^f   Kerrouche, N ^g   Sorba, V ^g   Villemagne, H ^g   Rhodes, L E ^h  

^a GOETHE UNIVERSITY   (Germany)

^b South East Dermatology ^*  (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g Galderma R and D   (France)

^h HOPE HOSPITAL   (United Kingdom)

Author keywords

Cosmetic outcome; Cryotherapy; Extremities; Methyl aminolaevulinate photodynamic therapy; Multiple actinic keratoses

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLD INJURY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DRUG EFFICACY; ESTHETICS; FEMALE; HUMAN; LIMB DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT SAFETY; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CRYOSURGERY; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 42049091682     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08488.x     Document Type: Article

References (22)

1. Halpern AC, Hanson LJ. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Int J Dermatol 2004 43 : 638 42.
2. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988 i : 795 7.
3. Hurwitz RM, Monger LE. Solar keratosis: an evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 1995 21 : 184.
4. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000 42 : 23 4.
5. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000 42 : S4 7.
6. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000 42 : S25 8.
7. Lubritz RR, Smolewski PA-C. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982 7 : 631 2.
8. Zouboulis CC. Cryosurgery in dermatology. Eur J Dermatol 1998 8 : 466 74.
9. Balkrishnan R, Cayce KA, Kulkarni AS et al. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatol Treat 2006 17 : 162 6.
10. Peng Q, Soler AM, Warloe T et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 2001 62 : 140 5.
11. Siddiqui AA, Perry MC, Scott JL. Topical methyl aminolevulinate. Am J Clin Dermatol 2004 5 : 127 37.
12. Angell-Petersen E, Sorensen R, Warloe T et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006 126 : 265 71.
13. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001 145 : 467 71.
14. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002 47 : 258 62.
15. Freeman M, Vinciullo C, Francis D, Spelman L. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003 14 : 99 106.
16. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003 48 : 227 32.
17. Morton C, Campbell S, Gupta G, Keohane S. Intra-individual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006 155 : 1029 36.
18. Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007 56 : 125 43.
19. Tarstedt M, Rosdahl I, Berne B et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol (Stockh) 2005 85 : 424 8.
20. Kurwa HA, Yong-Gee SA, Seed PT et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999 41 : 414 18.
21. Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996 192 : 246 51.
22. Lebwohl M, Dinehart S, Whiting D et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004 50 : 714 21.